The relationship between patients' prognosis and age in decisions regarding implantable cardioverter-defibrillator (ICD) therapy in the primary prevention of sudden death in heart failure patients is poorly understood and not addressed in randomized device trials. Thus, Dewland and colleagues created a survey that was sent to 3000 randomly selected primary care physicians and general cardiologists nationwide.
Read More
Overnight observation in the hospital after PCI remains the standard of care in the United States. However, because of the low complication rates, there has been a move toward same-day discharge in some countries.
Read More
Dabigatran etexilate, a direct thrombin inhibitor, is one of a new class of oral anticoagulants that was recently demonstrated in a Phase 3 trial to be effective for the prevention of stroke or systemic embolism (SSE) in patients with atrial fibrillation (AF).
Read More
